Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > market depth

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Feb 08, 2021 6:48pm

102 Views

Post# 32508017

market depth

Special terms and non-boardlot orders do not appear in Depth by Price +Vertical +Columnar +Horizontal

V:VXL Depth by Order @15:59:55

Bid			Ask
Broker	Size	Price	Price	Size	Broker
68 Leede	3,500	0.48	0.50	4,500	7 TD Sec
80 National Bank	1,500	0.48	0.51	2,000	2 RBC
124 Questrade	1,000	0.48	0.51	19,000	85 Scotia
2 RBC	15,000	0.48	0.51	41,500	7 TD Sec
68 Leede	1,000	0.475	0.51	8,000	7 TD Sec
2 RBC	15,000	0.475	0.51	3,000	2 RBC
68 Leede	1,000	0.47	0.51	3,000	2 RBC
19 Desjardins	10,000	0.47	0.51	20,000	2 RBC
7 TD Sec	15,000	0.47	0.51	3,000	2 RBC
2 RBC	5,000	0.47	0.52	29,000	2 RBC